Sunshine Biopharma (SBFM) Cash & Equivalents (2010 - 2026)
Sunshine Biopharma's Cash & Equivalents came in at $13.75 million for Q2 2026, up 33.4% from $10.31 million a year earlier and up 98.9% from the prior quarter.
Powered by 
Analysis
Sunshine Biopharma (SBFM) Cash & Equivalents (2010 - 2026) Analysis & Trends
At the end of FY2025, Sunshine Biopharma's Cash & Equivalents was $9.12 million, down 5.8% from FY2024.
- Cash & Equivalents has declined in each of the last three years, though with a five-year compound annual growth rate of 55.9% (FY2020 to FY2025).
- Going back by year, Cash & Equivalents was $9.69 million in FY2024 (-40.5%), $16.29 million in FY2023 (-25.4%), $21.83 million in FY2022 (+967.2%) and $2.05 million in FY2021 (+106.6%).
- The Q2 2026 figure represents the highest quarterly Cash & Equivalents since Q1 2024.
- Year-over-year, Cash & Equivalents increased in 1 of the last eight quarters, with an average decline of 18.8%.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q4 2022 (growth of 967.2%), and the weakest in Q3 2023 (a decline of 53.5%).
- Business Quant data shows SBFM's Cash & Equivalents at $6.91 million (Q1 2026), $9.12 million (Q4 2025) and $9.31 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.42 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.85 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 7.62 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 4.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 13.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.18 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 976.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 6.14 Bn |
| 10 | Sunshine Biopharma | 1.05 Mn | -38.04 Mn | 2.43 Mn | 13.75 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.75 Mn |
| Mar 31, 2026 | 6.91 Mn |
| Dec 31, 2025 | 9.12 Mn |
| Sep 30, 2025 | 9.31 Mn |
| Jun 30, 2025 | 10.31 Mn |
| Mar 31, 2025 | 8.12 Mn |
| Dec 31, 2024 | 9.69 Mn |
| Sep 30, 2024 | 12.21 Mn |
| Jun 30, 2024 | 11.51 Mn |
| Mar 31, 2024 | 17.43 Mn |
| Dec 31, 2023 | 16.29 Mn |
| Sep 30, 2023 | 18.85 Mn |
| Jun 30, 2023 | 19.73 Mn |
| Mar 31, 2023 | 19.29 Mn |
| Dec 31, 2022 | 21.83 Mn |
| Sep 30, 2022 | 40.56 Mn |
| Jun 30, 2022 | 41.73 Mn |
| Mar 31, 2022 | 13.18 Mn |
| Dec 31, 2021 | 2.05 Mn |
| Sep 30, 2021 | 2.39 Mn |
API Access
Sunshine Biopharma Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=SBFM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "SBFM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=SBFM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();